NTLA
Intellia Therapeutics Inc
Biotechnology company focused on CRISPR gene editing
CUSIP: 45826J105HealthcareUS2 holders
Total Value
$179.76M
Total Shares
2.47M
Net Share Change
+894.1K
Activity
2 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$179.41M2.47M shares
ADD+889.2K(+56.3%)
